With 2020 well underway, we thought it would be a great time to review some of the treatments currently available for managing symptoms of eczema which currently impacts an estimated 35 million Americans. With that in mind, we scoured the web and located a great article created by the National Eczema Association which you can… Read More

I think it’s safe to say, we’re all aware of countless articles that are created on a daily basis about skincare and the many methods you can pursue to improve your skin health. In the article linked below, you’ll find a list of the 21 most popular skincare tips found across the web, consolidated on… Read More

Marking the end of a two-decade-long drought, AKLIEF cream is the first Retinoid Molecule that’s been approved for the treatment of acne in over 20 years. The cream is designed to selectively target the most common retinoic acid receptor found in the skin. Giving patients and doctors a much-needed potential treatment option. Learn more about… Read More

We’ve all been there, standing in front of the mirror and all of a sudden something catches your eye. A new brown spot, seemingly appearing out of nowhere, has decided to call your skin it’s new home. No big deal, right? We all have a few moles. Most of the time you’d be correct. Moles… Read More

When it comes to acne medications, there are a plethora of options available for both oral and topical treatments. Each option has Its own benefits and side effects, making the importance of proper research and education a key step in identifying the best possible treatment for your unique situation. Follow the link below to learn… Read More

AbbVie, a research-based global biopharmaceutical company, announced that the FDA approved SKYRIZI™ for the treatment of moderate to severe plaque psoriasis in adults who are candidates for systemic therapy or phototherapy. Read the full announcement by AbbVie.

Read more about FDA Approves New Topical Treatment for Atopic Dermatitis

Read about advances in Serborrheic Keratosis on the Global Academy for Medical Education website.

FDA Approves OLUMIANT® (baricitinib) 2-mg Tablets for the Treatment of Adults with Moderately-to-Severely Active Rheumatoid Arthritis- click HERE to read more!